Beximco Pharmaceuticals Limited reported unaudited earnings results for the second quarter and six months ended December 31, 2017. For the quarter, the company reported net sales revenue of BDT 4,359,864,000 against BDT 3,864,993,000 a year ago. Profit from operations was BDT 1,033,345,000 against BDT 902,085,000 a year ago. Profit before tax was BDT 895,272, 000 against BDT 754,365,000 a year ago. Profit after tax was BDT 672,922,000 against BDT 597,991,000 a year ago. EPS was BDT 1.66 against BDT 1.47 a year ago. For the six months, the company reported the company reported net sales revenue of BDT 8,638,539,000 against BDT 7,630,591,000 a year ago. Profit from operations was BDT 1,991,759,000 against BDT 1,765,664,000 a year ago. Profit before tax was BDT 1,728,277,000 against BDT 1,464,066,000 a year ago. Profit after tax was BDT 1,317,418,000 against BDT 1,112,941,000 a year ago. EPS was BDT 3.25 against BDT 2.74 a year ago. NOCFPS was BDT 3.14 against BDT 2.56 a year ago. NAV per share was BDT 63.77 as on December 31, 2017 and BDT 59.07 as on December 31, 2016. Net cash generated from operating activities was BDT 1,275,346,000 against BDT 1,036,675,000 a year ago. Acquisition of property, plant and equipment was BDT 2,091,062,000 against BDT 922,622,000 a year ago. Acquisition of intangible assets was BDT 64,282,000 against BDT 31,033,000 a year ago.